Slingshot exists to unlock the potential of promising academic drug discovery by progressing it at pace.
As a new medicines accelerator, with an initial focus on small molecules, we look across the scientific ecosystem to find high potential breakthroughs.
We provide the platform that enables early-stage science to progress towards drug development in an ever-more complex biotech landscape. Slingshot ensures that innovative scientific discoveries have the opportunity to grow and develop.
Our team has the sector expertise, the operational infrastructure and the financial backing, through leading life science investor Syncona, to take ideas all the way to clinical readiness.
Company Details
- Employees
- 9
- Founded
- -
- Address
- London, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- London
Slingshot Therapeutics Questions
Slingshot Therapeutics's website is http://www.slingshot-accelerator.co.uk
Slingshot Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/slingshot-therapeutics
Slingshot Therapeutics has
9 employees.
View email and phone details for 9
employees at Slingshot Therapeutics.
Slingshot Therapeutics's industry is
Biotechnology Research
Slingshot Therapeutics's top competitors are
Northern Gritstone,
Slingshot Biosciences,
Beacon Therapeutics,
Kesmalea Therapeutics,
Resolution Therapeutics,
Syncona Limited,
Forcefield Therapeutics,
Omass Therapeutics,
Lucia Bio,
Purespring Therapeutics.
Slingshot Therapeutics's categories are Biotechnology Research
Slingshot Therapeutics's founding year is 2024
